세계의 차세대 시퀀싱 서비스 시장 - 규모, 점유율, 성장 분석 : 유형별, 기술별, 워크플로우별, 최종 용도별, 용도별, 지역별 산업 예측(2025-2032년)
Next-Generation Sequencing Services Market Size, Share, Growth Analysis, By Type, By Technology, By Workflow, By End Use, By Application, By Region - Industry Forecast 2025-2032
상품코드:1623670
리서치사:SkyQuest
발행일:2024년 12월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
차세대 시퀀싱 서비스 세계 시장 규모는 2023년에 84억 달러로 평가되었고, 예측 기간(2025-2032년)의 CAGR은 22.4%로, 2024년 102억 8,000만 달러에서 2032년에는 518억 달러로 성장할 전망입니다.
차세대 시퀀싱(NGS)은 초병렬 시퀀싱으로도 알려져 있으며, 신속하고 높은 처리량의 DNA 시퀀싱을 가능하게 하여 생명공학, 의료진단, 바이러스학 등의 분야에 혁명을 가져오고 있습니다. 이 기술은 기존의 생거 메소드에 비해 인간 유전체의 전체 염기 시퀀싱에 필요한 시간을 대폭 단축하여 임상 연구와 응용 연구를 강화합니다. 간편하고 시료 준비 및 분석을 간소화합니다. 임상 실험실에서의 응용이 확대되고 있는 NGS는 약리 유전체학에서 보다 신속한 질병 진단과 보다 효율적인 창약을 가능하게 합니다. 바이오마커를 확인하고 개인화된 치료 전략을 가능하게함으로써 NGS는 정밀의료로의 전환을 촉진하고 비교적 새로운 시장임에도 불구하고 분자 생물학과 유전학에 변화를 가져다주는 영향을 실증하고 있습니다.
목차
소개
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터의 방법
시장 규모 예측
시장의 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
억제요인과 과제
Porter's Five Forces 분석
주요 시장 인사이트
중요성공요인
경쟁도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
차세대 시퀀싱 서비스 시장 규모 : 유형별
시장 개요
인간 유전체 서열
단일 세포 시퀀싱
미생물 유전체에 기초한 서열 분석
유전자 제어 서비스
스몰 RNA 시퀀싱
칩 시퀀싱
기타 유전자 조절 기반 서비스
동물과 식물의 서열분석
기타 시퀀싱 서비스
차세대 시퀀싱 서비스 시장 규모 : 기술별
시장 개요
합성에 의한 시퀀싱
이온 반도체 시퀀싱
나노포어 시퀀싱
단일 분자 실시간 시퀀싱
기타 기술
차세대 시퀀싱 서비스 시장 규모 : 워크플로우별
시장 개요
사전 시퀀싱
시퀀싱
데이터 분석
차세대 시퀀싱 서비스 시장 규모 : 최종 용도별
시장 개요
대학 및 기타 연구기관
병원 및 클리닉
제약 및 생명 공학 기업
기타
차세대 시퀀싱 서비스 시장 규모 : 용도별
시장 개요
진단
종양학
생식에 관한 건강
감염증
희귀 유전성 질환
기타
창약
바이오마커의 발견
미생물 유전학 농업 동물 조사
기타 용도
차세대 시퀀싱 서비스 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
상위 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 프로파일
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
수익의 전년대비 비교(2022-2024)
주요 기업 프로파일
Illumina, Inc.(USA)
Thermo Fisher Scientific Inc.(USA)
BGI Genomics Co., Ltd.(China)
Eurofins Scientific SE(Luxembourg)
QIAGEN NV(Netherlands)
Agilent Technologies, Inc.(USA)
PerkinElmer, Inc.(USA)
Macrogen, Inc.(South Korea)
Pacific Biosciences of California, Inc.(USA)
Oxford Nanopore Technologies plc(UK)
Novogene Co., Ltd.(China)
Psomagen, Inc.(USA)
10x Genomics, Inc.(USA)
Takara Bio Inc.(Japan)
Zymo Research Corp.(USA)
CD Genomics(USA)
MedGenome Labs Pvt Ltd.(India)
Fulgent Genetics, Inc.(USA)
Personalis, Inc.(USA)
결론과 권장사항
JHS
영문 목차
영문목차
Global Next-Generation Sequencing Services Market size was valued at USD 8.4 billion in 2023 and is poised to grow from USD 10.28 billion in 2024 to USD 51.80 billion by 2032, growing at a CAGR of 22.4% during the forecast period (2025-2032).
Next-generation sequencing (NGS), also known as massively parallel sequencing, revolutionizes fields such as biotechnology, medical diagnostics, and virology by enabling rapid and high-throughput DNA sequencing. This technology significantly reduces the time required to sequence a complete human genome compared to traditional Sanger methods, enhancing clinical and applied research. NGS facilitates crucial DNA pre-sequencing steps, enabling streamlined sample preparation and analysis. Its growing application in clinical laboratories allows for quicker illness diagnosis and more efficient drug discovery in pharmacogenomics. By identifying biomarkers for early detection and enabling personalized treatment strategies, NGS catalyzes the shift towards precision medicine, demonstrating its transformative impact on molecular biology and genetics despite being relatively new to the market.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Next-Generation Sequencing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Next-Generation Sequencing Services Market Segmental Analysis
Global Next-Generation Sequencing Services Market is segmented by type, technology, workflow, end use, application and region. Based on type, the market is segmented into human genome sequencing, single cell sequencing, microbial genome-based sequencing, gene regulation services, animal & plant sequencing and other sequencing services. Based on technology, the market is segmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing and other technologies. Based on workflow, the market is segmented into pre-sequencing, sequencing and data analysis. Based on end use, the market is segmented into universities & other research entities, hospitals & clinics, pharma & biotech entities and others. Based on application, the market is segmented into diagnostics, oncology, reproductive health, infectious diseases, rare genetic disorders, others, drug discovery, biomarker discovery, microbial genetics, agriculture, and animal research and other applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Next-Generation Sequencing Services Market
The global Next-Generation Sequencing (NGS) services market is experiencing significant growth, primarily driven by advancements in clinical diagnostics across various fields, including forensics, reproductive health, and personalized medicine. NGS has emerged as the industry benchmark in clinical laboratories for diagnosing genetic disorders due to its analytical precision, high throughput capabilities, and cost-effectiveness. As the technology becomes more affordable, NGS is increasingly accessible, facilitating the diagnosis and treatment of rare diseases through genomic approaches. Additionally, the expansion of library preparation options and the growing pool of trained personnel are further propelling market growth, while ongoing improvements in sequencing technologies pave the way for novel therapies targeting Mendelian disorders and cancer.
Restraints in the Global Next-Generation Sequencing Services Market
The Global Next-Generation Sequencing (NGS) Services market faces several restraints, primarily stemming from legal and ethical challenges associated with DNA sequencing. These concerns encompass issues such as identifiability, the release of research findings, potential stereotyping, the adequacy of consent, stigma, inclusion, and unequal benefits among different groups. Such ethical considerations significantly hinder market growth. Additionally, the challenges of establishing in-house high-throughput devices and interpreting the complex data generated by NGS platforms are critical factors that are anticipated to further impede market expansion in the upcoming years, creating a cautious atmosphere among stakeholders in the industry.
Market Trends of the Global Next-Generation Sequencing Services Market
The Global Next-Generation Sequencing (NGS) Services market is witnessing a significant shift towards advanced technologies such as third-generation sequencing, which bypass traditional clonal amplification and polymerase chain reaction (PCR) methodologies. Innovations in single-molecule sequencing and real-time sequencing offer advantages, including longer read lengths and simplified preparatory processes, which reduce the risk of PCR-related errors. Platforms like Single-Molecule Real-Time (SMRT) sequencing and the FRET Sequencing platform are gaining traction due to their high accuracy and efficiency, propelling the market forward. The growing demand for precision medicine, genomics research, and personalized healthcare is further driving the adoption of these next-gen solutions, positioning NGS services as a pivotal market trend.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Next-Generation Sequencing Services Market Size by Type & CAGR (2025-2032)
Market Overview
Human Genome Sequencing
Single Cell Sequencing
Microbial Genome-Based Sequencing
Gene Regulation Services
Small RNA Sequencing
Chip Sequencing
Other Gene Regulation-Based Services
Animal & Plant Sequencing
Other Sequencing Services
Global Next-Generation Sequencing Services Market Size by Technology & CAGR (2025-2032)
Market Overview
Sequencing By Synthesis
Ion Semiconductor Sequencing
Nanopore Sequencing
Single-Molecule Real-Time Sequencing
Other Technologies
Global Next-Generation Sequencing Services Market Size by Workflow & CAGR (2025-2032)
Market Overview
Pre-Sequencing
Sequencing
Data Analysis
Global Next-Generation Sequencing Services Market Size by End Use & CAGR (2025-2032)
Market Overview
Universities & Other Research Entities
Hospitals & Clinics
Pharma & Biotech Entities
Others
Global Next-Generation Sequencing Services Market Size by Application & CAGR (2025-2032)
Market Overview
Diagnostics
Oncology
Reproductive Health
Infectious Diseases
Rare Genetic Disorders
Others
Drug Discovery
Biomarker Discovery
Microbial Genetics, Agriculture, And Animal Research
Other Applications
Global Next-Generation Sequencing Services Market Size & CAGR (2025-2032)
North America (Type, Technology, Workflow, End Use, Application)
US
Canada
Europe (Type, Technology, Workflow, End Use, Application)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type, Technology, Workflow, End Use, Application)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type, Technology, Workflow, End Use, Application)
Brazil
Rest of Latin America
Middle East & Africa (Type, Technology, Workflow, End Use, Application)
